Table 1.
Univariate analysis of patient cohort characteristics.
| Characteristic | No-BKV (n = 74) | BKNLow (n = 25) | BKNHi/B+ (n = 7) | p value | |||
|---|---|---|---|---|---|---|---|
| Proportion (%) | Mean | Proportion (%) | Mean | Proportion (%) | Mean | ||
| Female | 24/74 (32.4%) | 9/25 (36.0%) | 2/7 (28.6%) | 0.939 | |||
| Male | 50/74 (67.6%) | 16/25 (64.0%) | 5/7 (71.4%) | ||||
| Age at transplant (years) | 11.2 | 10.2 | 6.2 | 0.0369 | |||
| Ethnicity: White British+ | 45/68 (66.2%) | 17/25 (68.0%) | 5/7 (71.4%) | 1.000 | |||
| Living transplant donor | 43/74 (58.1%) | 18/25 (72.0%) | 6/7 (85.7%) | 0.228 | |||
| Cold ischaemia time (minutes) | 345.2 | 235.6 | 143.9 | 0.218 | |||
| Steroid-free regimen at latest follow up | 44/74 (59.5%) | 11/25 (44.0%) | 4/7 (57.1%) | 0.448 | |||
| MMF part of regimen at latest follow up | 55/74 (74.3%) | 16/25 (64.0%) | 5/7 (71.4%) | 0.543 | |||
| Exposure to anti-CMV therapy | 24/74 (32.4) | 10/25 (40.0%) | 3/7 (42.9%) | 0.735 | |||
| BPAR | 21/74 (28.4) | 6/25 (24.0%) | 2/7 (28.6%) | 0.933 | |||
| Graft failure | 7/74 (9.5%) | 1/25 (4.0%) | 0/7 (0.0%) | 0.802 | |||
| Death | 2/74 (2.7%) | 0/25 (0.0%) | 0/7 (0.0%) | 1.000 | |||
| Length of follow up (months) | 55.8 | 48.0 | 60.1 | 0.453 | |||
+Data not available for six patients. BPAR = biopsy proven acute rejection.